Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression

Experimental Cell Research

Volumn 248, Issue 1, 1999, Pages 110-114

  Boylan, John F ^a   Sharp, Diane M ^a   Leffet, Lynn ^a   Bowers, Alex ^a   Pan, Weijun ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Antibody; Cell cycle; Retinoblastoma protein

Indexed keywords

CYCLIN DEPENDENT KINASE; RETINOBLASTOMA PROTEIN;

ARTICLE; BINDING SITE; CELL CYCLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0033541419     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4389     Document Type: Article

References (15)

1. Mittnacht S. Control of pRb phosphorylation. Curr. Opin. Genet. Dev. 8:1998;21-27.
2. Herwig S., Strauss M. The retinoblastoma protein: A master regulator of cell cycle, differentiation and apoptosis. Eur. J. Biochem. 246:1997;581-601.
3. Bartek J., Bartkova J., Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res. 237:1997;1-6.
4. Ezhevsky S. A., Nagahara H., Vocero-Akbani A. M., Gius D. R., Wei M. C., Dowdy S. F. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:cdk4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. USA. 94:1997;10699-10704.
5. Zarkowska T., Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272:1997;12738-12746.
6. Connell-Crowley L., Harper J. W., Goodrich D. W. Cyclin D1/cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell. 8:1997;287-301.
7. Lundberg A. S., Weinberg R. A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:1998;753-761.
8. Sellers W. R., Novitch B. G., Miyake S., Heith A., Otterson G. A., Kaye F. J., Lassar A. B., Kaelin W. G. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12:1998;95-106.
9. Taya Y. RB kinases and RB-binding proteins: New point of view. Trends Biochem. Sci. 22:1997;14-17.
10. Brehm A., Miska E. A., McCance D. J., Reid J. L., Bannister A. J., Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature. 391:1998;597-601.
11. Magnaghi-Jaulin L., Groisman R., NAGuibneva P. R., Lorain S., LeVillain J. P., Troalen F., Trouche D., Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature. 391:1998;601-605.
12. Luo R. X., Postigo A. A., Dean D. C. Rb interacts with histone deacetylase to repress transcription. Cell. 92:1998;463-473.
13. Pan W., Sun T., Hoess R., Grafstrom R. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex. Carcinogenesis. 19:1998;765-769.
14. Kitagawa M., Higashi H., Jung H., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J., Segwaw K., Yoshida E., Nishimura S., Taya Y. The consensus motiff for phosphorylation by cyclin D1-cdk4 is different from that for phosphorylation by cyclin A/E-cdk2. EMBO J. 15:1996;7060-7069.
15. Zarkowska T. U. S., Harlow E., Mittnacht S. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs. Oncogene. 14:1997;249-254.